We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MAP market cap is 75.97M. The company's latest EPS is AUD -0.0317 and P/E is -5.99.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.83M | 2.91M | 3.73M | 4.69M | 5.42M |
| Operating Income | -4.77M | -6.72M | -7.6M | -11.95M | -13.86M |
| Net Income | -4.73M | -6.65M | -7.52M | -11.47M | -12.68M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 13.99M | 10.81M | 18.49M | 39.48M | 46.95M |
| Total Liabilities | 1.44M | 3.1M | 3.55M | 5.94M | 8.38M |
| Total Equity | 12.56M | 7.7M | 14.94M | 33.54M | 38.57M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.62M | -4.32M | -7.18M | -10.45M | -12.39M |
| Investing | -834k | -856k | -522k | -1.73M | -3M |
| Financing | 13.72M | 1.08M | 13.84M | 29.22M | 16.68M |
| Market Cap | 75.97M |
| Price to Earnings Ratio | -5.99 |
| Price to Sales Ratio | 13.97 |
| Price to Cash Ratio | 2.46 |
| Price to Book Ratio | 1.97 |
| Dividend Yield | - |
| Shares Outstanding | 399.82M |
| Average Volume (1 week) | 59.71k |
| Average Volume (1 Month) | 1.11M |
| 52 Week Change | -36.67% |
| 52 Week High | 0.45 |
| 52 Week Low | 0.15 |
| Spread (Intraday) | 0.01 (2.63%) |
| Company Name | Microba Life Sciences Ltd |
| Address |
level 10 brisbane, queensland 4000 |
| Website | https://www.microba.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
